Atea Pharmaceuticals Inc (AVIR)

Apr 30, 2026

AVIR Forecast, Price Target & Analyst Ratings | ATEA PHARMACEUTICALS INC (NASDAQ:AVIR) - ChartMill

Apr 30, 2026

Apr 29, 2026

Atea Pharmaceuticals (AVIR) price target increased by 25.00% to 10.20 - MSN

Apr 29, 2026

Apr 27, 2026

Atea Pharmaceuticals (NASDAQ: AVIR) sets 2026 proxy votes and outlines late-stage HCV strategy - Stock Titan

Apr 27, 2026

Apr 24, 2026

AVIR Stock Chart | ATEA PHARMACEUTICALS INC (NASDAQ:AVIR) - ChartMill

Apr 24, 2026

Apr 23, 2026

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Up 1.6%Still a Buy? - MarketBeat

Apr 23, 2026

Apr 22, 2026

AVIR (Atea Pharmaceuticals Inc.) falls 3% after reporting a wider-than-expected Q4 2025 loss per share.Community Driven Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 20, 2026

Atea Pharma (AVIR) Stock: Investment Risks (Buying Pressure) 2026-04-20Expert Insights - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 18, 2026

Atea Pharma (AVIR) Stock: Worthwhile Investment? (+0.70%) 2026-04-18Breakout Signals - Cổng thông tin điện tử Tỉnh Sơn La

Apr 18, 2026

Apr 13, 2026

Aug Outlook: Is Atea Pharmaceuticals Incs growth already priced in2026 Movers & Weekly High Return Forecasts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Growth Review: Is Atea Pharmaceuticals Inc attractive for institutional investorsQuarterly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Dip Buying: Will Atea Pharmaceuticals Inc face regulatory challenges2026 Valuation Update & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Hedge Fund Moves: Does Atea Pharmaceuticals Inc offer margin of safety2026 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Apr 09, 2026

Apr 07, 2026

AVIR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 07, 2026

Apr 06, 2026

Atea Pharmaceuticals (AVIR) price target increased by 33.33% to 8.16 - MSN

Apr 06, 2026

Apr 01, 2026

Atea Pharmaceuticals (NASDAQ:AVIR) Trading Surge Draws Market Attention - Kalkine Media

Apr 01, 2026

Apr 01, 2026

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Up 5.9%Here's Why - MarketBeat

Apr 01, 2026

Mar 30, 2026

Aug Gainers: Does Atea Pharmaceuticals Inc offer margin of safety2026 Weekly Recap & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 30, 2026

Mar 26, 2026

Vanguard disaggregation leaves Atea stake at 0% (NYSE: AVIR) - Stock Titan

Mar 26, 2026

Mar 24, 2026

ReAlta revamps leadership as pegtarazimod nears late-stage trials - Stock Titan

Mar 24, 2026

Mar 22, 2026

Stock Recap: Is Atea Pharmaceuticals Inc attractive for institutional investorsWatch List & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 22, 2026

Mar 22, 2026

If You Invested $1,000 in Atea Pharmaceuticals, Inc. (AVIR) - Stock Titan

Mar 22, 2026

Mar 19, 2026

Published on: 2026-03-20 02:34:07 - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga

Mar 18, 2026

Mar 17, 2026

AVIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 17, 2026

Mar 17, 2026

Hedge Fund Bets: Can Atea Pharmaceuticals Inc stock double in the next yearEarnings Summary Report & Precise Buy Zone Identification - baoquankhu1.vn

Mar 17, 2026

Mar 13, 2026

Atea Pharmaceuticals (NASDAQ: AVIR) officer exercises options for 60,000 shares - Stock Titan

Mar 13, 2026

Mar 10, 2026

Atea Pharmaceuticals (NASDAQ:AVIR) Hits New 12-Month HighHere's Why - MarketBeat

Mar 10, 2026

Mar 10, 2026

Atea Pharma presents data on compounds for hepatitis E - BioWorld MedTech

Mar 10, 2026

Mar 09, 2026

Atea Pharmaceuticals (AVIR) Price Target Raised by Evercore ISI - gurufocus.com

Mar 09, 2026

Mar 07, 2026

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 07, 2026

Mar 07, 2026

Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks - AOL.com

Mar 07, 2026

Mar 06, 2026

AVIR PE Ratio & Valuation, Is AVIR Overvalued - Intellectia AI

Mar 06, 2026

Mar 06, 2026

Atea Pharmaceuticals’ Earnings Call Flags Pivotal 2026 - TipRanks

Mar 06, 2026

Mar 06, 2026

Can Atea Pharmaceuticals Inc stock double in the next year2025 Winners & Losers & Consistent Income Trade Ideas - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com

Mar 06, 2026

Mar 06, 2026

Atea Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 06, 2026

Mar 05, 2026

Atea Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat

Mar 05, 2026

Mar 05, 2026

Atea Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:AVIR) 2026-03-05 - Seeking Alpha

Mar 05, 2026

Mar 05, 2026

Atea Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat

Mar 05, 2026

Mar 05, 2026

AVIR: Phase III HCV trials near completion, HEV pipeline expanded, and cash runway extends through 2027 - TradingView

Mar 05, 2026

Mar 05, 2026

Atea Pharma (AVIR) Earnings Call Transcript - AOL.com

Mar 05, 2026

Mar 05, 2026

Earnings call transcript: Atea Pharmaceuticals Q4 2025 sees stock rise despite EPS miss - Investing.com

Mar 05, 2026

Mar 05, 2026

AVIR: Phase 3 HCV trials near completion, with robust cash and new HEV candidate advancing - TradingView

Mar 05, 2026

Mar 05, 2026

Atea Pharmaceuticals (NASDAQ:AVIR) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat

Mar 05, 2026

Mar 05, 2026

Atea Pharmaceuticals 10-K: $0 Revenue, $(158.3)M Net Loss - TradingView

Mar 05, 2026